Neumirna Therapeutics ApS
41696451ActiveDeveloping miRNA-based therapies to treat complex neurological disease root causes.
Översikt
- 9
- Anställda
- Okänt
- Omsättning
- 2020
- Grundat
Nyckelbeslutsfattare
Shideh Morovati
Head of Communications
Andreas Wallnöfer
Independent Board Member
Ina Brünig-Traebert
Chief Development Officer
Manuel Toledo
Scientific Advisory Board Member
+31 fler kontakter i Funnelfeedr
Beskrivning
Neumirna is a biotechnology company founded in 2020 that specializes in developing miRNA-based therapies to address the root causes of neurological disorders. \n The company focuses on restoring neural network balance by targeting microRNAs, which are critical regulators of gene expression. \n Their...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- APS
- Momsnummer
- DK41696451
Beslutsfattare
35 kontakter i FunnelfeedrShideh Morovati
Head of Communications
Andreas Wallnöfer
Independent Board Member
Ina Brünig-Traebert
Chief Development Officer
Manuel Toledo
Scientific Advisory Board Member
Henrik Klitgaard
Co-Founder
Pavel Klein
Scientific Advisory Board Member
Peter Rasmussen
CFO
Jacqueline French
Scientific Advisory Board Member
Janine Erler
CEO
Milla Koistinaho
Board Member
Disa Tehler
Head of RNA Therapeutics
Luis Pareras
Chairman of the Board
Lars Hellerung Christiansen
Co-Founder
Ferenc Tracik, MD
CMO
Luis Pareras, MD, PhD
Chair of the Board
Ina Brünig-Traebert, PhD
Chief Development Officer
Lluís Riera-Ponsati, PhD
Director of Preclinical Development
Ellen K. Donnelly
Chief Executive Officer
Paolo Di Giorgio
Board Member
Sakari Kauppinen, PhD
Scientific Co-Founder
Andreas Wallnöfer, PhD
Board Member (Independent)
Henrik Klitgaard, PhD
Scientific Co-Founder and Board Member
Ellen Donnelly, PhD
CEO
Christian Christensen
Operations Officer
Övriga kontakter
Stine Norman-Hansen
Senior Scientist
Celia Palomo
PhD Student
Clara Mayer
Research Scientist
Lluís Riera-Ponsatí
Industrial Postdoc
+7 fler kontakter i Funnelfeedr
Liknande företag
20 liknande företag i FunnelfeedrCONTERA PHARMA A/S
19 anställdaDanish biotech company developing innovative RNA therapeutics for neurological disorders.
Muna Therapeutics ApS
15 anställdaDeveloping small molecule therapies to treat and stop neurodegenerative diseases.
Vesper Bio ApS
7 anställdaA clinical-stage biotech company developing oral therapies for neurodegeneration.
Mim Neurosciences AB
Developing novel small molecules to treat neurodegenerative diseases using NAD biology.
Abzu ApS
6 anställdaAbzu uses explainable AI to develop safer RNA therapeutics.
Utforska mer
Frågor om Neumirna Therapeutics ApS
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo